Ciprofloxacin Tablet
Product Images NDC 43063-410

5 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 43063-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adult Dosage Guidelines (Adult Dosage Guidelines)

Adult Dosage Guidelines (Adult Dosage Guidelines)
A data table listing infections treated with ciprofloxacin tablets, showing recommended dose, dosing frequency, and usual treatment duration. Conditions include skin and bone infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, urethral and cervical gonococcal infections, inhalational anthrax, plague, bacterial prostatitis, respiratory tract infections, urinary tract infections, cystitis, and sinusitis.*
FDA Label Image

Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)

Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)
A data table titled 'Pediatric Dosage Guidelines' showing dosage, frequency, and total duration for ciprofloxacin in pediatric patients. It lists treatment for complicated urinary tract or pyelonephritis, inhalational anthrax post-exposure, and plague with weight-based dosing, frequency intervals, and treatment duration ranging from 10 to 60 days.*
FDA Label Image

Ciprofloxacin-str1 (Ciprofloxacin Str1)

Ciprofloxacin-str1 (Ciprofloxacin Str1)
Chemical structure diagram of ciprofloxacin hydrochloride monohydrate, showing its molecular formula with labeled atoms and bonds.*
FDA Label Image

Steady Pharmacokinetic (Steady Pharmacokinetic)

Steady Pharmacokinetic (Steady Pharmacokinetic)
Table 13 presenting steady-state pharmacokinetic parameters of ciprofloxacin following multiple oral and intravenous doses in adults. Parameters include AUC (0-24h,ss) in µg·h/mL and Cmax,ss in µg/mL for various dosages and administration routes, such as 500 mg orally every 12 hours and 400 mg intravenously every 12 or 8 hours.*
FDA Label Image

43063410 Label (43063410)

43063410 Label (43063410)
Label for ciprofloxacin 250 mg oral tablets by PD-Rx Pharmaceuticals, Inc., containing 20 tablets. The label includes the NDC 43063-410-20 and a warning to keep the medication out of reach of children. It features dosage instructions in English and Spanish and states the drug is film-coated ciprofloxacin hydrochloride equivalent to 250 mg ciprofloxacin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.